Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients

被引:19
|
作者
Abreu, Monica T. [1 ]
Carvalheiro, Helena [1 ]
Rodrigues-Sousa, Tiago [1 ]
Domingos, Antonio [2 ]
Segorbe-Luis, Antonio [3 ,4 ]
Rodrigues-Santos, Paulo [1 ,5 ]
Margarida Souto-Carneiro, M. [1 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal
[2] Ctr Hosp Ctr Tejo, Hosp Torres Vedras, Dept Pneumol, Torres Vedras, Portugal
[3] Univ Coimbra, Fac Med, P-3004517 Coimbra, Portugal
[4] Hosp Univ Coimbra, Dept Immunoallergol, Coimbra, Portugal
[5] Univ Coimbra, Fac Med, Inst Immunol, P-3004517 Coimbra, Portugal
关键词
Memory B lymphocytes; Plasma cells; Multidrug-resistant tuberculosis; CD21; TLR9; CD69; TUMOR-NECROSIS-FACTOR; PULMONARY TUBERCULOSIS; PLASMA-CELLS; SJOGRENS-SYNDROME; DIFFERENTIATION; EXPRESSION; INFECTION; RESPONSIVENESS; ORGANIZATION; LYMPHOCYTES;
D O I
10.1007/s10238-013-0258-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The function of B cells in the immune response against Mycobacterium tuberculosis (Mtb) is still regarded as secondary, although major findings in mouse models of tuberculosis (TB) support their participation as regulators and antibody producers. However, studies in cohorts of TB or multidrug-resistant TB (MDR-TB) patients have failed to clearly identify changes in the circulating B cell pool. Therefore, in the present study we aimed at identifying alterations in the different B cell subpopulations in peripheral blood samples of HIV-negative pulmonary MDR-TB patients when compared to healthy donors. The data show, for the first time, that MDR-TB patients, similarly to what has been observed in other chronic inflammatory diseases, have a much lower frequency of peripheral blood unswitched IgD(+) CD27(+) memory B cells. Equally novel are the findings that in MDR-TB patients there is a reduction in the circulating plasma cell pool and that in MDR-TB there is an increased frequency of circulating type 1 transitional IgD(+) CD38(++), CD69(+) and TLR9(+) B cells. These results document disease-related shifts in peripheral blood B cell subsets in MDR-TB and suggest that such changes should be taken into account when designing new strategies to boost the cellular and humoral immune response against Mtb.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [21] Multidrug-Resistant Tuberculosis
    Spigelman, Mel
    Compton, Carolyn
    Gheuens, Jan
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22): : 2155 - 2155
  • [22] MULTIDRUG-RESISTANT TUBERCULOSIS
    GILLESPIE, SH
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1995, 53 (07): : 305 - 307
  • [23] Multidrug-resistant tuberculosis
    Keertan Dheda
    Fuad Mirzayev
    Daniela Maria Cirillo
    Zarir Udwadia
    Kelly E. Dooley
    Kwok-Chiu Chang
    Shaheed Vally Omar
    Anja Reuter
    Tahlia Perumal
    C. Robert Horsburgh
    Megan Murray
    Christoph Lange
    Nature Reviews Disease Primers, 10
  • [24] Multidrug-resistant tuberculosis
    Seaworth, BJ
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (01) : 73 - +
  • [25] Tuberculosis in household contacts of multidrug-resistant tuberculosis patients
    Grandjean, L.
    Crossa, A.
    Gilman, R. H.
    Herrera, C.
    Bonilla, C.
    Jave, O.
    Cabrera, J. L.
    Martin, L.
    Escombe, A. R.
    Moore, D. A. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (09) : 1164 - 1169
  • [26] Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis
    van Rijn, Sander P.
    van Altena, Richard
    Akkerman, Onno W.
    van Soolingen, Dick
    van der Laan, Tridia
    de Lange, Wiel C. M.
    Kosterink, Jos G. W.
    van der Werf, Tjip S.
    Alffenaar, Jan-Willem C.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (04) : 1229 - 1234
  • [27] Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis
    Lee, H. W.
    Kim, D. W.
    Park, J. H.
    Kim, S. -D.
    Lim, M. -S.
    Phapale, P. B.
    Kim, E. -H.
    Park, S. K.
    Yoon, Y. -R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (09) : 1161 - 1166
  • [28] IMPROVED OUTCOMES FOR PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
    TURETT, GS
    TELZAK, EE
    TORIAN, LV
    BLUM, S
    ALLAND, D
    WEISFUSE, I
    FAZAL, BA
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) : 1238 - 1244
  • [29] Costs of patients hospitalized for multidrug-resistant tuberculosis
    Rajbhandary, SS
    Marks, SM
    Bock, NN
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (08) : 1012 - 1016
  • [30] Diagnosis of COPD in patients with multidrug-resistant tuberculosis
    Baradzina, Halina L.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52